These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11039133)

  • 1. The effects of synthetic and natural surfactant on fluid balance in acute respiratory distress syndrome.
    Murdoch E; Kempley ST
    Eur J Pediatr; 2000 Oct; 159(10):767-9. PubMed ID: 11039133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of respiratory function and fluid balance in very low birthweight infants given artificial or natural surfactant or no surfactant treatment.
    Kavvadia V; Greenough A; Dimitriou G; Forsling M
    J Perinat Med; 1998; 26(6):469-74. PubMed ID: 10224604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
    da Costa DE; Pai MG; Al Khusaiby SM
    Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
    Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
    Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Sangstad OD
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
    Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
    J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of infants with birth weights less than 1000 g with respiratory distress syndrome treated with high-frequency ventilation and surfactant replacement therapy.
    Patel CA; Klein JM
    Arch Pediatr Adolesc Med; 1995 Mar; 149(3):317-21. PubMed ID: 7858694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
    Hamdan AH; Shaw NJ
    Pediatr Pulmonol; 1998 Mar; 25(3):191-5. PubMed ID: 9556011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Bratlid D; Farstad T
    Tidsskr Nor Laegeforen; 1994 Jan; 114(1):33-6. PubMed ID: 8296279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral blood flow velocity after surfactant instillation in preterm infants.
    van de Bor M; Ma EJ; Walther FJ
    J Pediatr; 1991 Feb; 118(2):285-7. PubMed ID: 1993962
    [No Abstract]   [Full Text] [Related]  

  • 11. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
    Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.
    Abbasi S; Bhutani VK; Gerdes JS
    J Pediatr; 1993 Mar; 122(3):446-52. PubMed ID: 8441104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD000144. PubMed ID: 10796308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative randomized study: administration of natural and synthetic surfactant to premature newborns with respiratory distress syndrome.
    Giannakopoulou C; Hatzidaki E; Korakaki E; Christodoulaki M; Margari KM; Mamoulakis D
    Pediatr Int; 2002 Apr; 44(2):117-21. PubMed ID: 11896865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy.
    Rubin BK; Ramirez O; King M
    Chest; 1992 Apr; 101(4):1080-5. PubMed ID: 1555424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
    Wach R; Darlow B; Bourchier D; Broadbent R; Knight D; Selby R
    N Z Med J; 1994 Jun; 107(980):234-7. PubMed ID: 8208494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue.
    Bevilacqua G; Parmigiani S;
    J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.